EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Prognostic value of coronary CTA-based AI plaque quantification in patients undergoing transcatheter aortic valve implantation

Kifah Hussain, Kevin Lee, Senthil S Balasubramanian, Lavisha Singh, Natasha Vyas, Fazal Hussain, Lucas Wathen, Mark J Ricciardi, Jonathon Leipsic, Campbell Rogers, David Davidson, Amit Pursnani

European Journal of Radiology · 2025-12 · 193 · 112445

DOI: 10.1016/j.ejrad.2025.112445 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift European Journal of Radiology, 2025-12. Verfasst von Kifah Hussain und 11 weiteren Autor:innen. Beteiligte Einrichtung: McGaw Medical Center of Northwestern University, Chicago, IL, USA; Endeavor NorthShore Cardiovascular Institute, Evanston, IL, USA; University of Chi…. Hauptthemen laut MEDLINE: Transcatheter Aortic Valve Replacement, Computed Tomography Angiography, Plaque, Atherosclerotic, Coronary Artery Disease. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Coronary artery disease can be concomitantly evaluated as part of the pre-transcatheter aortic valve implantation (TAVI) CT angiography (CTA). More recently it has been possible to perform quantitative plaque analysis on coronary CT angiography (CCTA). In this study, we aimed to assess the prognostic value of quantitative plaque volumes using Artificial Intelligence Quantified Coronary Plaque Analysis (AI-QCPA) on pre-TAVI CTA. METHODS: This observational cohort study included patients who underwent CTA for TAVI planning with concomitant evaluation for coronary atherosclerosis. Studies were performed on a 192-slice dual-source SIEMENS Force CT scanner without administration of pre-medication such as nitroglycerin or beta-blockers. We examined coronary plaque characteristics in TAVI patients with AI-QCPA and assessed differences in plaque volumes between patients who developed major adverse cardiac events (MACE) at one year versus those who did not. MACE was defined as a composite of all-cause mortality, stroke, myocardial infarction, heart failure hospitalization, or unplanned revascularization within 1-year post-TAVI. RESULTS: AI-QCPA was performed in 128 patients, with mean age of 80.1 ± 9.6 years (51.6 % male). A total of 24 patients developed MACE at 1 year. Median total plaque volume (TPV), calcified plaque volume (CPV), non-calcified plaque volume (NCPV), and low-attenuation plaque volume (LAPV) were significantly higher in patients who developed MACE. Multivariable regression analysis adjusting for Society of Thoracic Surgeons (STS) score, statin use, and revascularization pre-TAVI, showed that the highest quartile of NCPV (OR 4.56, 95 % CI 1.61-12.89; p = 0.004) and LAPV (OR 3.70, 95 % CI 1.29-10.60; p = 0.015) were independently associated with MACE. When adjusted for coronary stenosis total plaque and all plaque subtypes were independently associated with MACE. CONCLUSION: There is high volume of coronary plaque in patients undergoing TAVI assessed by AI-QCPA which is independently associated with the development of MACE one year post-TAVI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transcatheter Aortic Valve ReplacementComputed Tomography AngiographyPlaque, AtheroscleroticCoronary Artery DiseaseCoronary AngiographyArtificial IntelligenceAortic Valve StenosisHumansMaleFemaleAged, 80 and overPrognosisAgedReproducibility of ResultsTreatment OutcomeSensitivity and Specificity

Stichwörter der Autor:innen

Artificial intelligenceCoronary artery diseaseCoronary atherosclerosisMultidetector Computed tomographyTranscatheter aortic valve implantation

Autor:innen und Institutionen

  • McGaw Medical Center of Northwestern University, Chicago, IL, USA; Endeavor NorthShore Cardiovascular Institute, Evanston, IL, USA; University of Chicago, Pritzker School of Medicine, Chicago, IL, USA. Electronic addres…
  • Endeavor NorthShore Cardiovascular Institute, Evanston, IL, USA; University of Chicago, Pritzker School of Medicine, Chicago, IL, USA.
  • Endeavor NorthShore Cardiovascular Institute, Evanston, IL, USA; University of Chicago, Pritzker School of Medicine, Chicago, IL, USA; Piedmont Heart Institute, Fayetteville, GA, USA.
  • Endeavor NorthShore Cardiovascular Institute, Evanston, IL, USA.
  • Endeavor NorthShore Cardiovascular Institute, Evanston, IL, USA; Sinai Chicago, Chicago, IL, USA.
  • University of British Columbia, Vancouver, Canada.

Zitieren

APA

Hussain, K., Lee, K., Balasubramanian, S. S., Singh, L., Vyas, N., Hussain, F., Wathen, L., Ricciardi, M. J., Leipsic, J., Rogers, C., Davidson, D., & Pursnani, A. (2025). Prognostic value of coronary CTA-based AI plaque quantification in patients undergoing transcatheter aortic valve implantation. European Journal of Radiology, 193, 112445. https://doi.org/10.1016/j.ejrad.2025.112445

Vancouver

Hussain K, Lee K, Balasubramanian SS, Singh L, Vyas N, Hussain F, et al. Prognostic value of coronary CTA-based AI plaque quantification in patients undergoing transcatheter aortic valve implantation. European Journal of Radiology. 2025;193:112445. doi:10.1016/j.ejrad.2025.112445

BibTeX
@article{Hussain2025,
  author = {Hussain, Kifah and Lee, Kevin and Balasubramanian, Senthil S and Singh, Lavisha and Vyas, Natasha and Hussain, Fazal and Wathen, Lucas and Ricciardi, Mark J and Leipsic, Jonathon and Rogers, Campbell and Davidson, David and Pursnani, Amit},
  title = {Prognostic value of coronary CTA-based AI plaque quantification in patients undergoing transcatheter aortic valve implantation},
  journal = {European Journal of Radiology},
  year = {2025},
  volume = {193},
  pages = {112445},
  doi = {10.1016/j.ejrad.2025.112445}
}
Kostenlos starten →